Email this article Analysis of Blood Serum by the Method of Refractometry in Antitumor Therapy in Patients with Multiple Myeloma
- Authors: Plotnikova L.V.1, Polyanichko A.M.2, Kobeleva M.O.1, Nikekhin A.A.1, Uspenskaya M.V.1, Kayava A.V.1,3,4, Garifullin A.D.5, Voloshin S.V.5
-
Affiliations:
- ITMO University
- St. Petersburg State University
- Centre de Recherche en Biologie Cellulaire de Montpellier, UMR 5237 CNRS
- Institut de Biologie Computationnelle (IBC)
- Russian Scientific Research Institute of Hematology and Transfusiology
- Issue: Vol 124, No 1 (2018)
- Pages: 140-142
- Section: Geometric and Applied Optics
- URL: https://ogarev-online.ru/0030-400X/article/view/165621
- DOI: https://doi.org/10.1134/S0030400X18010149
- ID: 165621
Cite item
Open Access
Access granted
Subscription Access
Abstract
The serum of patients with multiple myeloma was examined by refractometric methods before and after the course of antitumor therapy. It was found that the amount of protein in the serum of patients with multiple myeloma, determined by the value of the serum refractive index, tended to decrease after the course of treatment. The value of the refractive index of blood serum can be used as an additional criterion for assessing the dynamics of changes in blood-serum properties during antitumor therapy.
About the authors
L. V. Plotnikova
ITMO University
Author for correspondence.
Email: ljusja@mail.ru
Russian Federation, St. Petersburg, 197101
A. M. Polyanichko
St. Petersburg State University
Email: ljusja@mail.ru
Russian Federation, St. Petersburg, 199034
M. O. Kobeleva
ITMO University
Email: ljusja@mail.ru
Russian Federation, St. Petersburg, 197101
A. A. Nikekhin
ITMO University
Email: ljusja@mail.ru
Russian Federation, St. Petersburg, 197101
M. V. Uspenskaya
ITMO University
Email: ljusja@mail.ru
Russian Federation, St. Petersburg, 197101
A. V. Kayava
ITMO University; Centre de Recherche en Biologie Cellulaire de Montpellier, UMR 5237 CNRS; Institut de Biologie Computationnelle (IBC)
Email: ljusja@mail.ru
Russian Federation, St. Petersburg, 197101; Montpellier; Montpellier, 34095
A. D. Garifullin
Russian Scientific Research Institute of Hematology and Transfusiology
Email: ljusja@mail.ru
Russian Federation, St. Petersburg, 191024
S. V. Voloshin
Russian Scientific Research Institute of Hematology and Transfusiology
Email: ljusja@mail.ru
Russian Federation, St. Petersburg, 191024
Supplementary files
